Indication
Osteoarthritis of the Hip
1 clinical trial
2 products
Clinical trial
A Randomized, Open-label Study Comparing the Systemic Exposure to Triamcinolone Acetonide Following a Single Intra-articular Dose of Extended-release FX006 or Immediate-release TAcs (Triamcinolone Acetonide Suspension) in Patients With Osteoarthritis of the Shoulder (Glenohumeral Joint) or HipStatus: Completed, Estimated PCD: 2018-10-09
Product
FX006Product
TAcs